Skip to content

Corporate Management Information Main Article

U.S.-based Daiichi Sankyo Leaders

Our leadership team inspires and challenges every aspect of the organization to develop life-changing solutions for the patients of today and tomorrow. Along with their peers who sit overseas, this dynamic and experienced group of U.S.-based leaders enable us to create innovative medicines that can change the standard of care.

Corporate Management Bio

Corporate Management

Ken Keller

Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business

Koji Sato

Head of U.S. Corporate Division

Ken Takeshita, MD

Global Head, Research & Development

Daniel Switzer

Head of U.S. Oncology Business Division

Global Oncology Business (U.S.-based leaders)

Ken Keller

Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business

Rich Jones

Vice President, Global Oncology Business Strategy & Analytics

Mary Pinder-Schenck, MD

Head of Global Oncology Medical Affairs

U.S. Corporate Division

Koji Sato

Head of US Corporate Division

Matt Allegrucci

Chief Ethics and Compliance Officer

Patricia A. Barbieri, Esq.

Senior Vice President, General Counsel & Secretary

James Felix

Vice President, Information Technology and Regional IT Head Americas

Simon King

Chief People Officer

Kevin Smith

Head of Supply Chain and Technical Operations

Mila Tartakovsky

Vice President, Finance and Administration

Martin Unverdorben MD, PhD, Professor of Medicine, FACC

Vice President, Global Specialty Medical Affairs

Xin (Sam) Ye, PhD, MS

Head of Global Specialty Value Access & Pricing

Lin Zhang, MD, PhD

Head of Clinical Safety and Pharmacovigilance

Research & Development (U.S.-based leaders)

Ken Takeshita, MD

Global Head, Research & Development

Michael Grosso, MD, FACS

Global Head of Specialty Medicine Clinical Development

Dalal Nesheiwat, PharmD

Global Head Clinical Science

Marielle Cohard Radice, MD

Global Head of Development Operations

Eric Richards, MS, MPH

Head of Global Regulatory Affairs

Mark Rutstein, MD

Head of Global Oncology Clinical Development

Michele Schmidt

Head of Global Asset and Portfolio Management

Dale E. Shuster, PhD

Head of Global Precision Medicine

Atsushi Tsukamoto, PhD. MSc.

Head of Therapeutic Area Strategies

U.S. Oncology Business

Daniel Switzer

Head of U.S. Oncology Business Division

Barry Fortner, PhD.

Head of U.S. Oncology Medical Affairs

Brian Hauser

Vice President, U.S. Business Operations

Kara Reheis

Vice President, U.S. Marketing

Lerryn Trzcinski

Vice President, U.S. Market Access

Global Business Development (U.S.-based leader)

Stu Mackey, JD

Global Head Business Development

Last Updated: April 2023